OOIR: Observatory of International Research

Papers

(The TQCC of Clinical Microbiology Reviews is 39. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-09-01 to 2024-09-01.)

Article	Citations
Coronavirus Disease 2019–COVID-19	698
New β-Lactam–β-Lactamase Inhibitor Combinations	286
Tools and Techniques for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)/COVID-19 Detection	228
A Comprehensive Review on the Role of the Gut Microbiome in Human Neurological Disorders	205
Remdesivir against COVID-19 and Other Viral Diseases	189
Performance and Application of 16S rRNA Gene Cycle Sequencing for Routine Identification of Bacteria in the Clinical Microbiology Laboratory	147
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): a Systemic Infection	147
Critical Determinants of Cytokine Storm and Type I Interferon Response in COVID-19 Pathogenesis	141
Pathogenesis of Gram-Negative Bacteremia	125
Microsporidiosis in Humans	112
Mobile Oxazolidinone Resistance Genes in Gram-Positive and Gram-Negative Bacteria	107
Yersinia pestis: the Natural History of Plague	104
The Changing Face of the Family Enterobacteriaceae (Order: “ Enterobacterales ”): New Members, Taxonomic Issues, Geographic Expansion, and	101
Advances in the Microbiology of Stenotrophomonas maltophilia	96
Evolutionary Pathways and Trajectories in Antibiotic Resistance	95
Epidemiology, Pathophysiology, Diagnosis, and Management of Cerebral Toxoplasmosis	91
Convalescent Plasma Therapy for COVID-19: State of the Art	90
Viral Respiratory Pathogens and Lung Injury	90
COVID-19 Convalescent Plasma and Clinical Trials: Understanding Conflicting Outcomes	73
Pathogenesis of Respiratory Viral and Fungal Coinfections	73
Human Listeriosis	71
Mechanisms of Drug-Induced Tolerance in Mycobacterium tuberculosis	71
Laboratory Diagnosis of Lyme Borreliosis	71
Giardia duodenalis: Biology and Pathogenesis	70
SARS-CoV-2 Antiviral Therapy	68

Klebsiella oxytoca Complex: Update on Taxonomy, Antimicrobial Resistance, and Virulence	64
Molecular Epidemiology of Human Cryptosporidiosis in Low- and Middle-Income Countries	62
Progress and Challenges in the Prevention, Diagnosis, and Management of Cytomegalovirus Infection in Transplantation	57
Environmental, Microbiological, and Immunological Features of Bacterial Biofilms Associated with Implanted Medical Devices	54
Machine Learning for Antimicrobial Resistance Prediction: Current Practice, Limitations, and Clinical Perspective	52
Staphylococcus lugdunensis: a Skin Commensal with Invasive Pathogenic Potential	50
Interplay between Candida albicans and Lactic Acid Bacteria in the Gastrointestinal Tract: Impact on Colonization Resistance, Microbial Carriage, Opportunistic Infection, and Host Immunity	49
The Five Ds of Outpatient Antibiotic Stewardship for Urinary Tract Infections	49
Helicobacter pylori Infection, Its Laboratory Diagnosis, and Antimicrobial Resistance: a Perspective of Clinical Relevance	47
Staphylococcus aureus in Agriculture: Lessons in Evolution from a Multispecies Pathogen	44
Antiviral Approaches against Influenza Virus	44
Sensitivity to Vaccines, Therapeutic Antibodies, and Viral Entry Inhibitors and Advances To Counter the SARS-CoV-2 Omicron Variant	44
The Echo of Pulmonary Tuberculosis: Mechanisms of Clinical Symptoms and Other Disease-Induced Systemic Complications	42
SARS-CoV-2 and Health Care Worker Protection in Low-Risk Settings: a Review of Modes of Transmission and a Novel Airborne Model Involving Inhalable Particles	41
Updated Review onNocardiaSpecies: 2006–2021	39